» Articles » PMID: 26700712

Local and Global Function Model of the Liver

Overview
Specialties Oncology
Radiology
Date 2015 Dec 25
PMID 26700712
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To develop a local and global function model in the liver based on regional and organ function measurements to support individualized adaptive radiation therapy (RT).

Methods And Materials: A local and global model for liver function was developed to include both functional volume and the effect of functional variation of subunits. Adopting the assumption of parallel architecture in the liver, the global function was composed of a sum of local function probabilities of subunits, varying between 0 and 1. The model was fit to 59 datasets of liver regional and organ function measures from 23 patients obtained before, during, and 1 month after RT. The local function probabilities of subunits were modeled by a sigmoid function in relating to MRI-derived portal venous perfusion values. The global function was fitted to a logarithm of an indocyanine green retention rate at 15 minutes (an overall liver function measure). Cross-validation was performed by leave-m-out tests. The model was further evaluated by fitting to the data divided according to whether the patients had hepatocellular carcinoma (HCC) or not.

Results: The liver function model showed that (1) a perfusion value of 68.6 mL/(100 g · min) yielded a local function probability of 0.5; (2) the probability reached 0.9 at a perfusion value of 98 mL/(100 g · min); and (3) at a probability of 0.03 [corresponding perfusion of 38 mL/(100 g · min)] or lower, the contribution to global function was lost. Cross-validations showed that the model parameters were stable. The model fitted to the data from the patients with HCC indicated that the same amount of portal venous perfusion was translated into less local function probability than in the patients with non-HCC tumors.

Conclusions: The developed liver function model could provide a means to better assess individual and regional dose-responses of hepatic functions, and provide guidance for individualized treatment planning of RT.

Citing Articles

Current Insights into Molecular Mechanisms and Potential Biomarkers for Treating Radiation-Induced Liver Damage.

Saha B, Pallatt S, Banerjee A, Banerjee A, Pathak R, Pathak S Cells. 2024; 13(18.

PMID: 39329744 PMC: 11429644. DOI: 10.3390/cells13181560.


Time variation of high-risk groups for liver function deteriorations within fluctuating long-term liver function after hepatic radiotherapy in patients with hepatocellular carcinoma.

Tsai Y, Yu P, Nien H, Lu T Eur J Med Res. 2024; 29(1):104.

PMID: 38326881 PMC: 10848403. DOI: 10.1186/s40001-024-01692-z.


Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma.

Zaki P, Chuong M, Schaub S, Lo S, Ibrahim M, Apisarnthanarax S Technol Cancer Res Treat. 2023; 22:15330338231206335.

PMID: 37908130 PMC: 10621304. DOI: 10.1177/15330338231206335.


Evolution of Response-Based Radiotherapy for Hepatocellular Cancer.

Elaimy A, Cao Y, Lawrence T Cancer J. 2023; 29(5):266-271.

PMID: 37796644 PMC: 10558084. DOI: 10.1097/PPO.0000000000000679.


Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study.

Huang J, Li L, Liu F, Tan B, Yang Y, Jiang B J Hepatocell Carcinoma. 2023; 10:573-586.

PMID: 37056420 PMC: 10086221. DOI: 10.2147/JHC.S404895.


References
1.
Fan M, Marks L, Hollis D, Bentel G, Anscher M, Sibley G . Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?. J Clin Oncol. 2001; 19(2):543-50. DOI: 10.1200/JCO.2001.19.2.543. View

2.
Dawson L, McGinn C, Normolle D, Ten Haken R, Walker S, Ensminger W . Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2000; 18(11):2210-8. DOI: 10.1200/JCO.2000.18.11.2210. View

3.
Dawson L, Normolle D, Balter J, McGinn C, Lawrence T, Ten Haken R . Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002; 53(4):810-21. DOI: 10.1016/s0360-3016(02)02846-8. View

4.
Gottlieb M, Stratton H, Newell J, Shah D . Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man. Arch Surg. 1984; 119(3):264-8. DOI: 10.1001/archsurg.1984.01390150006002. View

5.
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J . Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21(1):109-22. DOI: 10.1016/0360-3016(91)90171-y. View